rs587776805
|
|
Adenocarcinoma of lung (disorder)
|
GTGTGGGCTC |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs397516975
|
|
Adenocarcinoma of lung (disorder)
|
AGCATACGTGATG |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1554350382
|
|
Adenocarcinoma of lung (disorder)
|
AGTC |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs121913469
|
|
Adenocarcinoma of lung (disorder)
|
CC |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs121913366
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs121913351
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1131692238
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs1131692237
|
|
Adenocarcinoma of lung (disorder)
|
G |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1057519788
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs121913229
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain.
|
15737014 |
2005 |
rs1057519788
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Acquired resistance to crizotinib from a mutation in CD74-ROS1.
|
23724914 |
2013 |
rs1057519784
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Ceritinib in ALK-rearranged non-small-cell lung cancer.
|
24670165 |
2014 |
rs1057519782
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Ceritinib in ALK-rearranged non-small-cell lung cancer.
|
24670165 |
2014 |
rs1057519781
|
|
Adenocarcinoma of lung (disorder)
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Ceritinib in ALK-rearranged non-small-cell lung cancer.
|
24670165 |
2014 |
rs150036236
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.
|
20942962 |
2010 |
rs1057519787
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.
|
22908275 |
2012 |
rs1057519784
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.
|
24327273 |
2014 |
rs863225281
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.
|
24327273 |
2014 |
rs863225281
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.
|
24327273 |
2014 |
rs139429793
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation.
|
24212795 |
2011 |
rs113488022
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs371769427
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.730 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs371769427
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.730 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs28929495
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.720 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913338
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.720 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |